Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-879-5 | CAS number: 2475232-73-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin corrosion: no adverse effects in vitro, OECD TG 431, Orovecz 2018
Skin irritation: no adverse effects in vitro, OECD TG 439, Orovecz 2019
Eye irritation: no adverse effects in vitro, OECD TG 438, Orovecz 2019
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- Juyl 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: not specified
- Details on animal used as source of test system:
- EpiSkinTM (Manufacturer: SkinEthic, France, Batch No.: 18-EKIN-008, Expiry Date: 26 February 2018) is a three-dimensional human epidermis model. Adult human-derived epidermal keratinocytes are seeded on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen. A highly differentiated and stratified epidermis model is obtained after 13-day culture period comprising the main basal, supra basal, spinous and granular layers and a functional stratum corneum
- Justification for test system used:
- EpiSkin model has been validated for corrosivity testing in an international validation study and its use is recommended by the relevant OECD guideline 431.
- Vehicle:
- physiological saline
- Details on test system:
- Preparation: adult human-derived epidermal keratinocytes are seeded on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen. A highly differentiated and stratified epidermis model is obtained after a 13-day culture period comprising the main basal, supra basal, spinous and granular layers and a functional stratum corneum.
Units: EpiSkinTM plate containing up to 12 reconstructed epidermis units (area: 0.38 cm2) each reconstructed epidermis is attached to the base of a tissue culture vessel with an O-ring set and maintained on nutritive agar for transport.
Plate: 12-well assay plate
Punch: EpiSkinTM biopsy punch for easy sampling of epidermis
A flask of sterile “Maintenance Medium” (Batch No.: 18 MAIN3 008; Exp. Date: 28 February 2018)
A flask of sterile “Assay Medium” (Batch No.: 18 ESSC 007; Exp. Date: 28 February 2018) - Control samples:
- yes, concurrent vehicle
- yes, concurrent positive control
- yes, concurrent MTT non-specific colour control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied: 20 mg , then 100 µL physiological salline was added
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 50 µL
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 50 µL - Duration of treatment / exposure:
- Incubation for 4 hours
- Duration of post-treatment incubation (if applicable):
- 3 hours after MTT solution was added to each well below the skin units
- Number of replicates:
- Two
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Mean cell viability of two discs
- Value:
- 64.6
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The results of the in vitro EpiSkin corrosivity assay show that the substance is non-corrosive to skin.
- Executive summary:
An in vitro skin corrosivity test was conducted under GLP to OECD TG 431, using a reconstructed human epidermis model. Disks of the EpiSkin model (two units) were treated with powdered test material (20 mg per unit) and 100 µL of physiological saline and then incubated for 4 hours at room temperature. Exposure was terminated by rinsing the units with phosphate buffered saline solution. The cell viability of each disk was assessed by incubating the tissues for 3 hours with MTT solution. The precipitated formazan crystals were then extracted using acidified isopropanol and quantified spectrophotometrically at 570 nm. The two negative control epidermis units were treated with physiological saline (0.9% w/v NaCl solution), and the two positive control units were treated with glacial acetic acid. Two additional disks were used to provide an estimate of colour contribution from the test item. For each treated tissue the cell viability was expressed as the percentage relative to the negative control. The cell viability in the units treated with the test substance was 64.6%, which is above the threshold of 35%. The substance wsa considered to be non-corrosive to skin.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 2015
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: not specified
- Details on animal used as source of test system:
- EpiSkin (Manufacturer: SkinEthic, France, Batch No.: 19-EKIN-029, Expiry Date: 22 July 2019) is a three-dimensional human epidermis model. Adult human-derived epidermal keratinocytes are seeded on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen. A highly differentiated and stratified epidermis model is obtained after 13-day culture period comprising the main basal, supra basal, spinous and granular layers and a functional stratum corneum (Tinois et al., 1994). Its use for skin irritation testing involves topical application of test materials to the surface of the epidermis, and the subsequent assessment of their effects on cell viability.
- Justification for test system used:
- The EpiSkin has been validated for irritation testing in an international validation study and its use is recommended by the relevant OECD guideline for irritation testing (OECD No. 439); therefore, it was considered to be suitable for this study.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- Units: EpiSkinTM plate containing up to 12 reconstructed epidermis units (area: 0.38 cm2) each reconstructed epidermis is attached to the base of a tissue culture vessel with an O-ring set and maintained on nutritive agar for transport.
Plate: 12-well assay plate
Punch: EpiSkinTM biopsy punch for easy sampling of epidermis
Medium: A flask of sterile “Maintenance Medium” (Batch No.: 19 MAIN3 032; Exp. Date: 24 July 2019)
A flask of sterile “Assay Medium” (Batch No.: 19 ESSC 030; Exp. Date: 24 July 2019) - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- yes, concurrent MTT non-specific colour control
- Amount/concentration applied:
- A volume of 10 μL of distilled water was applied to the epidermal surface to improve the contact of the test substance with the epidermis. Then, an aliquot of 10 mg test substance was applied evenly to the skin surface. Aliquots of 20 μL of negative control (phosphate buffered saline) and positive control (5% w/v sodium dodecyl sulphate) were applied evenly to the skin surfaces.
- Duration of treatment / exposure:
- 15 minutes ± 0.5 minutes
- Duration of post-treatment incubation (if applicable):
- 42 hours ± 1 hour
- Number of replicates:
- Three
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Results of three replicates
- Value:
- >= 88.8 - <= 97.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Mean cell viability was 93.2%
- Other effects / acceptance of results:
- After receipt, the two indicators included in the package of the delivered kits (reflecting the storage temperature history and the pH) were checked. Based on the observed colours, the epidermis units were in a suitable condition for use in the assay.
The mean OD value of the three negative control tissues was in the recommended range (0.848). Standard deviation of the viability results for negative control samples was 4.1%.
The positive control treated tissues showed 3.7% viability demonstrating the proper performance of the assay. The standard deviation of the viability results for positive control samples was 0.6%.
The standard deviation of viability values of the three test item-treated tissue samples in the MTT assay was 4.4%.
The mean OD value of the blank samples (acidified isopropanol) was 0.048.
All these parameters met the acceptability criteria, therefore the study was considered to be valid. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The results of this in vitro study indicated that the substance was not irritating to skin under the conditions of the test.
- Executive summary:
An in vitro skin irritation study was conducted under GLP to OECD TG 439 in a reconstructed human epidermis model. Three disks each of the EpiSkin model were treated with the test substance, the negative control phosphate buffered saline or the positive control substance sodium dodecyl sulphate (applied as 5% w/v solution). The disks were incubated at room temperature for a duration of 15 minutes. Exposure was stopped by rinsing the units with phosphate buffered saline. The cleaned epidermis units were then incubated at 37 °C for 42 hours in an incubator with 5% CO2 in a >95% relative humified atmosphere. After this incubation, MTT ("Thiazolyl blue") solution was added to the units, which were then incubated for a further 3 hours to determine cell viability. The precipiated formazan crystals were then extracted using acidified isopropanol and quantified spectrophotometrically at 570 nm.
Two additional disks were used to provide an estimate of colour contribution from the test item. For each treated tissue, the viability was expressed as a percentage relative to the negative control. The mean cell viability of the disks treated with the substance was 93.2% compared to the cell viability of the negative control disks. This is clearly above the threshold of 50% viability, indicating that the test substance was not irritating to the skin under the conditions of the test. The mean cell viability of the plates treated with the positive control substance was 3.7%, showing the suitability of the applied test system.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 2018
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- chicken
- Strain:
- other: COBB 500 and ROSS 308
- Details on test animals or tissues and environmental conditions:
- Source: TARAVIS KFT. 9600 Sárvár, Rábasömjéni u 129., Hungary
Collection: heads were collected by a technician from a commercial abattoir after approximately 7 weeks old chicken were slaughtered for human consumption. Heads were inspected for appropriate quality and wrapped with paper moistened with saline and then placed in a sealed plastic box. The heads were then immediately transported to the laboratory at ambient temperature and processed within 2 hours of collection in each experiment.
Eye selection: delivered heads were removed from the plastic box and placed on soft paper. The eyelids were carefully cut away with scissors, avoiding damage of the cornea. One small drop of 2% w/v fluorescin solution was applied onto the cornea surface for a few seconds. The eye was subsequently rinsed with 20 mL of physiological saline. The treated cornea was then examined with a hand-held slit lamp or microscope to ensure that it was undamaged. If the cornea was in a good condition, the eyeball was carefully removed from the orbit.
Preparation of the eye: the eyeball was removed without cutting off the optical nerve too short avoiding pressure on the eye to prevent distortion of the cornea and subsequent corneal opacity. The removed eyeball was placed onto damp paper and the nictitating membrane was cut away with other connective tissue. The prepared eye was kept on the wet papers in a closed box so that the appropriate humidity was maintained.
Eyes examination and acclimatisation: the prepared eye was placed in a steel retainer. The cornea was positioned vertically with the eye in the correct relative position, by avoiding too much pressure on the eye. The clamp with the eyeball was transferred to a chamber of the superfusion apparatus. The retainer holding the eye was positioned in such a way that the entire cornea was supplied with physiological saline dripping from a stainless steel tube, at a rate of approximately 3-4 drops per minute or 0.1 to 0.15 mL/minute. The chamber was closed except for manipulations and examinations, to maintain temperature and humidity. The appropriate number of eyes (nine to twelve) were selected, placed in the superfusion apparatus, and examined again with the slit lamp microscope. The focus was adjusted to clearly see the physiological saline which was flowing on the cornea surface. Eyes with a high baseline fluorescine staining or corneal opacity score were rejected. The cornea thickness was measured with an optical pachymeter on a slit-lamp microscope, which was set at a 0.095 mm slit-width. Any eye with cornea thickness deviating by more than 10% from the mean value of all eyes, or eyes showing any other signs of damage were rejected and replaced. Once the selected eyes were appropriate for the test, acclimatisation was started for a period of about 45 to 60 minutes. The chambers of the superfusion apparatus were held at a controlled temperature of 32 ± 1.5 °C. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- An aliquot of 30 mg powdered test substance was applied onto the entire surface of the cornea. The positive control eyes were treated in a similar way with 30 mg powdered imidazole. The negative control eye was treated with 30 μL of physiological saline.
- Duration of treatment / exposure:
- 10 seconds
- Duration of post- treatment incubation (in vitro):
- The negative and positive control eyes as well as all test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse. Minor variations within approximately ±5 minutes were considered acceptable.
- Number of animals or in vitro replicates:
- Three for test substance, one for negative and three for positive control
- Details on study design:
- At the end of the acclimatisation period, a zero reference measurement was recorded for corneal thickness and opacity to serve as a base line (t = 0) for each individual eye. The corneal thickness of the eyes should not change by more than 5% between the -45 min and the zero time. No changes in thickness (0.0%) were observed in any eye in each experiment. Base line values were required to evaluate any potential test item related effect after treatment. All eyes were considered to be suitable for the assay.
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- Experiment I
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- Experiment II
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- Experiment I
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- Experiment II
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- Experiment I
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- Experiment II
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- Experiment I and II
- Value:
- >= 12.2 - <= 29.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Positive control
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- Experiment I and II
- Value:
- 4
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Positive control
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- Experiment I and II
- Value:
- >= 2.5 - <= 3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Positive control
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- Experiment I and II
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Negative control
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- Experiment I and II
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Netative control
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- Experiment I and II
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Negative control
- Other effects / acceptance of results:
- The results from all eyes used met the quality control standards. The negative control and positive control results were in good correlation with historic data. This experiment was considered to be valid. Historical data for negative control (n = 497) were -3.2 to 3.4% after 75 minutes and -4.8 to 3.4% after 240 minutes for corneal swelling, maximum 0.5 for opacity change and 0.5 for fluorescine retention change. Historical data for positive control (n = 221) were -6.6 to 25% after 75 minutes and -15.9 to 36.7% after 240 minutes for corneal swelling, 3.5 to 4.0 for opacity change and 2.0 to 3.0 for fluorescine retention change.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results of the in vitro isolated chicken eye assy, the substance is non-irritating to the eye.
- Executive summary:
An in vitro eye irritation study was conducted under GLP to OECD TG 438, using the isolated chicken eye test. The study used three eyes for the treatment with test substance, alongside with one negative and three positive control eyes in each of two experiments. After the zero reference (baseline) measurement, each eye in the treatment group was held in a horizontal position and 30 mg of powdered test material was applied onto the centre of teh cornea such that the entire surface was covered. After 10 seconds of exposure, the surface was rinsed with physiological saline. In both experiments, the positive control eyes were treated in a similar way with 30 mg of powdered imidazole and the negative control eye was treated with 30 μL of physiological saline (i.e. 0.9% NaCl solution). Corneal thickness, corneal opacity and fluorescein retention changes were measured and any morphological effects (such as pitting or loosening of the epithelium) were evaluated over a four-hour period. In experiment I, no corneal swelling, no cornea opacity, and no fluorescein retention change was observed during the observation period in any of the three treated eyes. Test substance was stuck on all corneal surfaces after the rinsing, and the surfaces were cleared at 30 minutes after the rinsing. The negative and positive control group results demonstrated the validity of the study and the sensitivity of the test system.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
On the basis of the results of the available reliale and valid in vitro studies on skin corrosion and irritation and eye irritation, the substance does not need to be classified under Regulation (EC) No. 1278/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.